Delivery Order SPE2DB24D2205-SPE2DB25FEGPV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,324.10 to AmerisourceBergen Drug Corp for the supply of Lotrel 10-40 mg capsules (100 count). This competitive, firm fixed-price delivery order was awarded on December 19, 2025, with an ultimate completion date of December 22, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under...
- The Defense Logistics Agency awarded a competitive, firm fixed-price delivery order to AmerisourceBergen Drug Corp for $1,398.98 on February 3, 2026, for the supply of Lotrel 5-10 mg capsules (100-count units). This award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.9 million through December 31, 2031. The delivery order is scheduled for ultimate completion on...
- The Defense Logistics Agency awarded a $17,627 delivery order to Amerisourcebergen Drug Corporation for the supply of 100 capsules of Lotrel 10-20 mg. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for the pharmaceutical supplies to be delivered to a facility in Conshohocken, Pennsylvania by September 15, 2023. Amerisourcebergen will serve as the prime contractor on the fixed-price order, which supports the Defense Logistics Agency's...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lotrel 10-20 mg capsules. The $31,616.33 firm fixed price contract has an ultimate completion date of August 22, 2024. This order is part of a larger indefinite delivery contract between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999, for delivering a comprehensive range of medical commodities to support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $37,639.78 firm fixed-price contract is for the supply of Lotrel 10-20 mg capsules, a prescription medication. This contract is not set aside for any specific business category. AmerisourceBergen is one of the largest pharmaceutical distributors in the United States and has been awarded numerous federal contracts to provide a wide range of pharmaceutical and...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $14,503.71 to Amerisourcebergen Drug Corporation for the supply of 100 capsules of Lotrel 10-20 mg to a location in Conshohocken, Pennsylvania. The order was placed under an existing indefinite-delivery/indefinite-quantity contract vehicle and is to be fulfilled by July 11, 2023 at the latest. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform as the prime...
- The Defense Logistics Agency Troop Support Medical awarded a $74,714.94 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 capsules of Lotrel 10-20 mg. The place of performance is Conshohocken, Pennsylvania. The delivery order has a period of performance from July 12, 2023 through July 13, 2023 to supply pharmaceutical products in support of Department of Defense medical readiness programs. Amerisourcebergen Drug Corporation will serve as the prime contractor to...
- The Defense Logistics Agency awarded a $772 delivery order to Amerisourcebergen Drug Corporation for the supply of 100 capsules of Lotrel 10-20 mg. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for the pharmaceutical products to be shipped to a facility in Conshohocken, Pennsylvania by July 28, 2023. The award is a firm fixed-price delivery order with no set-aside designation. As a major provider of medical supplies and...
- The Defense Logistics Agency awarded a $21,887.67 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561682702 LOTREL 10-20 MG CAPSULE 100S. The prime contractor Amerisourcebergen Drug Corporation, operating from its Conshohocken, Pennsylvania office, will deliver the requested pharmaceutical products to the Defense Logistics Agency by August 3, 2023 in support of the agency's medical supply chain requirements. No subcontractors or set aside designations...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $8,855.44 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 100 capsules of Lotrel 10-20 mg to support the Defense Logistics Agency's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of 3 days from August 18 through August 21, 2023. As the prime contractor, Amerisourcebergen will be responsible for...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGPVDelivery Order
The Defense Logistics Agency awarded a $37,798.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Lotrel 10-20 mg capsules (100-count units) on August 21, 2025, with an ultimate completion date of August 22, 2025. This non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to fulfill this pharmaceutical supply requirement. The company maintains an extensive portfolio of federal contract awards demonstrating its capability to deliver a wide spectrum of medical products and pharmaceuticals to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Lotrel, an antihypertensive combination medication, exemplifies the company's role in supplying critical brand-name and generic pharmaceutical products across multiple therapeutic domains to support military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.8k | 8/21/25 |